[1] |
Tirelli G, Gardenal N, Gatto A, et al. Head and neck immunoglobulin G4 related disease: Systematic review[J]. J Laryngol Otol, 2018, 132(12):1046-1050.
doi: 10.1017/S0022215118002153
|
[2] |
Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease[J]. BMJ, 2020, 369: m1067.
|
[3] |
Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD[J]. Mod Rheumatol, 2021, 31(3):529-533.
doi: 10.1080/14397595.2020.1859710
pmid: 33274670
|
[4] |
Uhliarova B, Svec M. Kuttnertumor[J]. Bratisl Lek Listy. 2013, 114(1):36-38.
|
[5] |
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011[J]. Mod Rheumatol, 2012, 22(1):21-30.
doi: 10.1007/s10165-011-0571-z
pmid: 22218969
|
[6] |
张文, 董凌莉, 朱剑, 等. IgG4相关性疾病诊治中国专家共识[J]. 中华内科杂志, 2021, 60(3):192-206.
|
[7] |
张美兰, 陈海兰, 庄勇, 等. IgG4相关性疾病的超声表现[J]. 中国超声医学杂志, 2022, 38(11):1307-1310.
|
[8] |
Fujita A, Sakai O, Chapman MN, et al. IgG4-related disease of the head and neck: CT and MR imaging manifestations[J]. Radio Graphics, 2012, 32(7):1945-1958.
|
[9] |
张骜丹, 边杰, 罗佳文, 等. IgG4相关性涎腺炎的CT诊断价值[J]. 新发传染病电子杂志, 2017, 2(3):175-178.
|
[10] |
Maehara T, Moriyama M, Nakamura S. Pathogenesis of IgG4-related disease: A critical review[J]. Odontology, 2019, 107(2):127-132.
doi: 10.1007/s10266-018-0377-y
pmid: 30019169
|
[11] |
Michailidou D, Schwartz DM, Mustelin T, et al. Allergic aspects of IgG4-related disease: Implications for pathogenesis and therapy[J]. Front Immunol, 2021, 12: 693192.
|
[12] |
Shirakashi M, Yoshifuji H, Kodama Y, et al. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: A multicentrestudy[J]. Sci Rep, 2018, 8(1):10262.
doi: 10.1038/s41598-018-28405-x
pmid: 29980706
|
[13] |
Campochiaro C, Della-Torre E, Lanzillotta M, et al. Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease[J]. Eur J Intern Med, 2020, 74: 92-98.
doi: S0953-6205(19)30467-4
pmid: 31901297
|
[14] |
Della-Torre E, Lanzillotta M, Campochiaro C, et al. Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: An observational prospective open-label cohort study[J]. Eur J Intern Med, 2021, 84: 63-67.
doi: 10.1016/j.ejim.2020.12.006
pmid: 33386207
|
[15] |
Perez Alamino R, Martínez C, Espinoza LR. IgG4-associated vasculitis[J]. Curr Rheumatol Rep, 2013, 15(8):348.
doi: 10.1007/s11926-013-0348-9
pmid: 23794082
|
[16] |
Sun ZP, Zhang ZY, Fu KY, et al. Diagnostic accuracy of parotid CT for identifying Sjögren's syndrome[J]. Eur J Radiol, 2012, 81(10):2702-2709.
doi: 10.1016/j.ejrad.2011.12.034
pmid: 22285605
|
[17] |
Kise Y, Ikeda H, Fujii T, et al. Preliminary study on the application of deep learning system to diagnosis of Sjögren's syndrome on CT images[J]. Dentomaxillofac Radiol, 2019, 48(6):20190019.
|
[18] |
Wang C, Yu Q, Li SY, et al. Carcinoma ex pleomorphic adenoma of major salivary glands: CT and MR imaging findings[J]. Dentomaxillofac Radiol, 2021, 50(7):20200485.
|
[19] |
何小桐, 王琼, 吴亚平, 等. 口腔颌面颈部Castleman病: 6例临床病例报告和文献复习[J]. 口腔医学, 2019, 39(3):246-249.
|
[20] |
Abdelwaed HMR. Non-Hodgkin's lymphoma of the oral cavity and maxillofacial region: A pathologist viewpoint[J]. Expert Rev Hematol, 2018, 11(9):737-748.
doi: 10.1080/17474086.2018.1506326
pmid: 30058399
|
[21] |
王开, 康非吾. 涎腺黏膜相关淋巴组织型淋巴瘤报告1例及文献系统分析[J]. 口腔医学, 2018, 38(12):1137-1140.
|
[22] |
Sangwan A, Goyal A, Bhalla AS, et al. Kimura disease: A case series and systematic review of clinico-radiological features[J]. Curr Probl Diagn Radiol, 2022, 51(1):130-142.
doi: 10.1067/j.cpradiol.2020.10.003
pmid: 33250297
|